Mina K. Chung, MD
Section of Cardiac Electrophysiology, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Mina K. Chung, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Mina K. Chung, MD
Section of Cardiac Electrophysiology, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Mina K. Chung, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Mina K. Chung, MD
Section of Cardiac Electrophysiology, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Mina K. Chung, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Jacquelyn Slomka, PhD, RN
Assistant Professor, The University of Texas Health Science Center at Houston

Address: Jacquelyn Slomka, PhD, RN, The University of Texas Health Science Center at Houston, School of Public Health, RAS E-607, 1200 Hermann Pressler, Houston, TX 77030; e-mail: [email protected]

Jacquelyn Slomka, PhD, RN
Assistant Professor, The University of Texas Health Science Center at Houston

Address: Jacquelyn Slomka, PhD, RN, The University of Texas Health Science Center at Houston, School of Public Health, RAS E-607, 1200 Hermann Pressler, Houston, TX 77030; e-mail: [email protected]

Jacquelyn Slomka, PhD, RN
Assistant Professor, The University of Texas Health Science Center at Houston

Address: Jacquelyn Slomka, PhD, RN, The University of Texas Health Science Center at Houston, School of Public Health, RAS E-607, 1200 Hermann Pressler, Houston, TX 77030; e-mail: [email protected]

Adrian W. Messerli, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Herbert D. Aronow, MD, MPH
Department of Cardiovascular Medicine, The Cleveland Clinic

Dennis L. Sprecher, MD
Adjunct staff, The Cleveland Clinic; Director, Dyslipidemia, Discovery Medicine, GlaxoSmithKline; formerly head, Section of Cardiac Prevention, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis Sprecher, MD, GlaxoSmithKline, 709 Swedelan Rd, UW2900, King of Prussia, PA 19406

Dr. Aronow has indicated that he serves as a consultant for and is on the speaker’s bureau of the Pfizer corporation.

Dr. Sprecher became employed by GlaxoSmithKline corporation after this paper was written and accepted.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Adrian W. Messerli, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Herbert D. Aronow, MD, MPH
Department of Cardiovascular Medicine, The Cleveland Clinic

Dennis L. Sprecher, MD
Adjunct staff, The Cleveland Clinic; Director, Dyslipidemia, Discovery Medicine, GlaxoSmithKline; formerly head, Section of Cardiac Prevention, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis Sprecher, MD, GlaxoSmithKline, 709 Swedelan Rd, UW2900, King of Prussia, PA 19406

Dr. Aronow has indicated that he serves as a consultant for and is on the speaker’s bureau of the Pfizer corporation.

Dr. Sprecher became employed by GlaxoSmithKline corporation after this paper was written and accepted.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Adrian W. Messerli, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Herbert D. Aronow, MD, MPH
Department of Cardiovascular Medicine, The Cleveland Clinic

Dennis L. Sprecher, MD
Adjunct staff, The Cleveland Clinic; Director, Dyslipidemia, Discovery Medicine, GlaxoSmithKline; formerly head, Section of Cardiac Prevention, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Dennis Sprecher, MD, GlaxoSmithKline, 709 Swedelan Rd, UW2900, King of Prussia, PA 19406

Dr. Aronow has indicated that he serves as a consultant for and is on the speaker’s bureau of the Pfizer corporation.

Dr. Sprecher became employed by GlaxoSmithKline corporation after this paper was written and accepted.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Ashish Atreja, MD, MPH
Department of Internal Medicine, The Cleveland Clinic

Cynthia Abacan, MD
Department of Internal Medicine, The Cleveland Clinic

Angelo Licata, MD, PhD
Department of Endocrinology, The Cleveland Clinic

Address: Angelo Licata, MD, Department of Endocrinology, A53, The Cleveland Clinic Foundation 9500 Euclid Avenue, Cleveland, OH 44195

Ashish Atreja, MD, MPH
Department of Internal Medicine, The Cleveland Clinic

Cynthia Abacan, MD
Department of Internal Medicine, The Cleveland Clinic

Angelo Licata, MD, PhD
Department of Endocrinology, The Cleveland Clinic

Address: Angelo Licata, MD, Department of Endocrinology, A53, The Cleveland Clinic Foundation 9500 Euclid Avenue, Cleveland, OH 44195

Ashish Atreja, MD, MPH
Department of Internal Medicine, The Cleveland Clinic

Cynthia Abacan, MD
Department of Internal Medicine, The Cleveland Clinic

Angelo Licata, MD, PhD
Department of Endocrinology, The Cleveland Clinic

Address: Angelo Licata, MD, Department of Endocrinology, A53, The Cleveland Clinic Foundation 9500 Euclid Avenue, Cleveland, OH 44195

Brian F. Mandell, MD, PhD
Department of Rheumatic Diseases, The Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, Deputy Editor, Cleveland Clinic Journal of Medicine, NA32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Brian F. Mandell, MD, PhD
Department of Rheumatic Diseases, The Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, Deputy Editor, Cleveland Clinic Journal of Medicine, NA32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Brian F. Mandell, MD, PhD
Department of Rheumatic Diseases, The Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, Deputy Editor, Cleveland Clinic Journal of Medicine, NA32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Joseph Bernstein, MD
Assistant professor of orthopedic surgery, University of Pennsylvania, Philadelphia

Tony Quach, BA
University of Pennsylvania, Philadelphia

Address: Joseph Bernstein, MD, Department of Orthopedic Surgery, University of Pennsylvania, 424 Stemmler Hall, Philadelphia, PA 19104; e-mail: [email protected]

Joseph Bernstein, MD
Assistant professor of orthopedic surgery, University of Pennsylvania, Philadelphia

Tony Quach, BA
University of Pennsylvania, Philadelphia

Address: Joseph Bernstein, MD, Department of Orthopedic Surgery, University of Pennsylvania, 424 Stemmler Hall, Philadelphia, PA 19104; e-mail: [email protected]

Joseph Bernstein, MD
Assistant professor of orthopedic surgery, University of Pennsylvania, Philadelphia

Tony Quach, BA
University of Pennsylvania, Philadelphia

Address: Joseph Bernstein, MD, Department of Orthopedic Surgery, University of Pennsylvania, 424 Stemmler Hall, Philadelphia, PA 19104; e-mail: [email protected]

White EA, Rabinovitz HS, Greene RS, Oliviero M, Kopf A

White EA, Rabinovitz HS, Greene RS, Oliviero M, Kopf A

White EA, Rabinovitz HS, Greene RS, Oliviero M, Kopf A

Nordness M, Zacharisen MC

Nordness M, Zacharisen MC

Nordness M, Zacharisen MC

Ackerman AB

Ackerman AB

Ackerman AB